Epigenetic drivers in diffuse intrinsic pontine gliomas (DIPG)


About this


Diffuse intrinsic pontine glioma (DIPG) is the leading cause of death in children with brain cancers and is considered to be uniformly fatal with median overall survival of only 8-11 months. Radiation is the only therapy proven to increase survival and that by meager 3-6 months. These tumors cannot be surgically resected due to the diffuse involvement within the pons. Sequencing of DIPG genomes revealed histone mutations found in more than 80% of DIPG cases. The most common mutation occurs in the gene encoding histone 3.3 resulting in nonsynonymous change to methionine at position 27 (H3.3K27M). Smaller percentage of patients have histone 3.1 mutation variants (H3.1K27M). The histone mutations result in genome wide epigenetic changes of chromatin methylation and acetylation resulting in transcriptional dysregulation which is thought to be crucial to DIPG oncogenesis and progression. We generated epigenetic maps of the alterations induced by the aforementioned histone mutations and found profound alterations on the enhancer chromatin landscape.

Ask The


Ask the scientists

What are the goals of this project?

We seek to employ WGS to identify copy number and structural alterations in the non-coding genome that may drive remodeling of enhancer chromatin in DIPG.analyze

Specimen Data

The Children's Brain Tumor Network contributed to this project by providing access to the Pediatric Brain Tumor Atlas.

Explore the data in these informatics portals